Unii-T4np8G3K6q manufacturers
- Batabulin
-
- $73.00
-
2026-07-18
- CAS:195533-53-0
- Purity: 99.85%
- Supply Ability: 10g
- Batabulin
-
- $73.00
-
2026-07-18
- CAS:195533-53-0
- Purity: 99.85%
- Supply Ability: 10g
|
| | Unii-T4np8G3K6q Basic information |
| Product Name: | Unii-T4np8G3K6q | | Synonyms: | Batabulin;Batabulin [inn];Benzenesulfonamide, 2,3,4,5,6-pentafluoro-N-(3-fluoro-4-methoxyphenyl)-;N-(3-Fluoro-4-methoxyphenyl)-2,3,4,5,6-pentafluorobenzenesulfonamide;T 138067;Tl 057;Unii-T4np8G3K6q;2,3,4,5,6-pentafluoro-N-(3-fluoro-4-methoxyphenyl)benzenesulfonamide | | CAS: | 195533-53-0 | | MF: | C13H7F6NO3S | | MW: | 371.26 | | EINECS: | | | Product Categories: | | | Mol File: | 195533-53-0.mol |  |
| | Unii-T4np8G3K6q Chemical Properties |
| Boiling point | 403.3±55.0 °C(Predicted) | | density | 1.629±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 100 mg/mL (269.35 mM) | | form | Solid | | pka | 5.74±0.10(Predicted) | | color | White to off-white |
| | Unii-T4np8G3K6q Usage And Synthesis |
| Uses | Treatment of various refractory cancers,
including hepatocellular carcinoma, breast, colon and
non-small cell lung cancer. | | in vivo | Batabulin (T138067; 40 mg/kg; intraperitoneal injection; once per week; on days 5, 12, and 19; male athymic nude mice) treatment impairs the growth of the drug-sensitive CCRF-CEM tumors[1]. | Animal Model: | Male athymic nude mice (nu/nu) (6-8 week-old, 20-25 g) injected with
CCRF-CEM cells[1] | | Dosage: | 40 mg/kg | | Administration: | Intraperitoneal injection; once per week; on days 5, 12, and 19 | | Result: | Impaired the growth of the drug-sensitive CCRF-CEM tumors.
|
|
| | Unii-T4np8G3K6q Preparation Products And Raw materials |
|